Arena Shares Finish Higher After FDA Rejects Obesity Drug Lorcaserin

by | Oct 25, 2010 | Towing

Arena Pharmaceuticals announced, as expected, the U.S. Food and Drug Administration did not approve its weight loss drug Lorcaserin for patients who are obese and overweight because the potential risks outweigh the minimal effi…